Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study on the Efficacy and Safety of Ticagrelor in the Treatment of Ischemic Cerebrovascular Disease

NCT05716646 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05716646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study on the Efficacy and Safety of Ticagrelor in the Treatment of Ischemic Cerebrovascular Disease
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2023
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction, ischemic cerebrovascular disease, nervous system diseases, stroke